Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 166 participants.
Also called NCT04434586
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 166 participants
- Sponsor
- Registry
-
NCT04434586
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT04434586. Randomized; single masking; primary purpose treatment. Start 2020-06-16 (actual); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
- Acronym
- TOCAF
- Condition
- Superficial Femoral Artery Stenosis
- Condition
- Claudication
- Condition
- Ischemic Leg
- Intervention (Device)
- femoropopliteal revascularization for TASC C or TASC D lesion
- Lead sponsor
- University Hospital, Lille
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct04434586- Content hash
21c3a191338597a35845a518b05dd71c7870f68578125b4babc28c8572affeab